Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Healthcare (NHC) Interest Expenses (2016 - 2025)

Historic Interest Expenses for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $1.5 million.

  • National Healthcare's Interest Expenses fell 1641.79% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year increase of 32852.49%. This contributed to the annual value of $4.1 million for FY2024, which is 117623.46% up from last year.
  • Per National Healthcare's latest filing, its Interest Expenses stood at $1.5 million for Q3 2025, which was down 1641.79% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare's Interest Expenses registered a high of $2.3 million during Q4 2024, and its lowest value of $46000.0 during Q1 2024.
  • For the 5-year period, National Healthcare's Interest Expenses averaged around $634555.6, with its median value being $176500.0 (2021).
  • In the last 5 years, National Healthcare's Interest Expenses plummeted by 5306.12% in 2024 and then soared by 447826.09% in 2025.
  • Over the past 5 years, National Healthcare's Interest Expenses (Quarter) stood at $188000.0 in 2021, then tumbled by 40.43% to $112000.0 in 2022, then tumbled by 50.0% to $56000.0 in 2023, then soared by 4091.07% to $2.3 million in 2024, then tumbled by 37.96% to $1.5 million in 2025.
  • Its Interest Expenses stands at $1.5 million for Q3 2025, versus $2.0 million for Q2 2025 and $2.1 million for Q1 2025.